Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Brazil
  4. Bolsa de Valores de Sao Paulo
  5. Diagnósticos da América S.A.
  6. News
  7. Summary
    DASA3   BRDASAACNOR1

DIAGNÓSTICOS DA AMÉRICA S.A.

(DASA3)
  Report
SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news

Brazilian hospital operator Care files for IPO

03/31/2021 | 02:24pm EDT

SAO PAULO, March 31 (Reuters) - Brazilian hospital chain Care has filed for an initial public offering of roughly 790.5 million reais ($139.42 million), amid a dealmaking boom in Brazil's healthcare sector, according to a securities filing on Wednesday.

Care's plans for an IPO follows a raft of share offerings by hospital operators. Rede D'Or successfully concluded in December a 11.4 billion reais IPO and rivals such as Kora Saude Participacoes and Dasa are expected to conclude share offerings in the coming weeks.

Rising demand for services and an aging population have fueled deals in Brazil's healthcare sector, as Reuters reported earlier.

Hospital Care and its shareholders plan to sell at least 31 million shares between 22.50 reais and 28.50 reais. If overallotments are sold, the offering may increase by 35%. The price will be set on April 20.

The hospital operator has among its shareholders Brazilian private equity firm Crescera and Elie Horn, the founder of homebuilder Cyrela.

It operates 11 hospital, with 1,206 beds, and also sells healthcare plans, in a business model similar to Hapvida and Notre Dame Intermedica.

Itau BBA, BTG Pactual, Bank of America, XP, Safra and UBS BB will manage the offering. ($1 = 5.6700 reais) (Reporting by Aluisio Alves, writing by Carolina Mandl; editing by Diane Craft)


© Reuters 2021
Stocks mentioned in the article
ChangeLast1st jan.
BANCO BTG PACTUAL S.A. -2.15% 15.95 End-of-day quote.39.76%
BANK OF AMERICA CORPORATION 0.12% 40.5 Delayed Quote.33.62%
CYRELA BRAZIL REALTY S.A. EMPREENDIMENTOS E PARTICIPAÇÕES -0.10% 19.67 End-of-day quote.-33.28%
DIAGNÓSTICOS DA AMÉRICA S.A. 0.77% 45.85 End-of-day quote.-36.76%
HAPVIDA PARTICIPAÇÕES E INVESTIMENTOS S.A. -0.20% 15.25 End-of-day quote.-0.07%
NOTRE DAME INTERMÉDICA PARTICIPAÇÕES S.A. -1.65% 83 End-of-day quote.5.95%
REDE D'OR SÃO LUIZ S.A. -1.27% 69.04 End-of-day quote.1.08%
All news about DIAGNÓSTICOS DA AMÉRICA S.A.
08/12Diagnósticos Da América S.A. Reports Earnings Results for the Second Quarter ..
CI
07/22GLOBAL MARKETS LIVE : AT&T, American Airlines, Biogen, Netflix, ABB...
07/08DIAGNÓSTICOS DA AMERICA S A : Dados Econômico-Financeiros
PU
06/23DIAGNÓSTICOS DA AMÉRICA S.A.(BOVESPA : DASA3) added to Brazil Special Corporate ..
CI
06/10DIAGNÓSTICOS DA AMERICA S A : Reunião da Administração
PU
06/01Diagnósticos da América S.A. acquired Hospital da Bahia S/A for BRL 850 milli..
CI
04/14Brazil's IPOs lose steam amid virus surge, political turmoil
RE
04/07DIAGNÓSTICOS DA AMERICA S A : Brazilian medical lab firm Dasa raises $590 mln in..
RE
04/06DIAGNÓSTICOS DA AMERICA S A : Brazil's Dasa prices share at 58 reais, below orig..
RE
04/06DIAGNÓSTICOS DA AMERICA S A : Brazil's Dasa prices shares at 58 reais, below ori..
RE
More news
Financials
Sales 2021 10 613 M 2 009 M 2 009 M
Net income 2021 736 M 139 M 139 M
Net Debt 2021 6 329 M 1 198 M 1 198 M
P/E ratio 2021 33,5x
Yield 2021 0,49%
Capitalization 25 120 M 4 732 M 4 754 M
EV / Sales 2021 2,96x
EV / Sales 2022 2,41x
Nbr of Employees 18 142
Free-Float 42,0%
Chart DIAGNÓSTICOS DA AMÉRICA S.A.
Duration : Period :
Diagnósticos da América S.A. Technical Analysis Chart | DASA3 | BRDASAACNOR1 | MarketScreener
Technical analysis trends DIAGNÓSTICOS DA AMÉRICA S.A.
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 7
Last Close Price 45,85 BRL
Average target price 79,50 BRL
Spread / Average Target 73,4%
EPS Revisions
Managers and Directors
Pedro de Godoy Bueno Chief Executive Officer
Felipe da Silva Guimaraes Finance Director
Romeu Côrtes Domingues Co-Chairman
Dulce Pugliese de Godoy Bueno Co-Chairman
Danilo Ricardo Bono Zimmermann Technical Director